Hyperliquid Strategies Inc (NASDAQ:PURR – Get Free Report) was the recipient of unusually large options trading on Tuesday. Traders purchased 6,372 call options on the stock. This represents an increase of approximately 52% compared to the average volume of 4,192 call options.
Analyst Upgrades and Downgrades
Several equities research analysts have issued reports on the company. Wall Street Zen upgraded Hyperliquid Strategies to a “hold” rating in a research report on Saturday, February 21st. Weiss Ratings assumed coverage on Hyperliquid Strategies in a research report on Monday, March 2nd. They set a “sell (e)” rating on the stock. Cantor Fitzgerald increased their target price on Hyperliquid Strategies from $6.00 to $8.00 and gave the stock an “overweight” rating in a research report on Monday, May 11th. Maxim Group initiated coverage on Hyperliquid Strategies in a research report on Friday, April 24th. They issued a “buy” rating and a $10.00 price objective on the stock. Finally, Chardan Capital increased their price objective on Hyperliquid Strategies from $8.15 to $8.45 and gave the stock a “buy” rating in a research report on Thursday, February 12th. Three research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Hyperliquid Strategies has an average rating of “Moderate Buy” and a consensus target price of $8.82.
View Our Latest Analysis on Hyperliquid Strategies
Institutional Trading of Hyperliquid Strategies
Hyperliquid Strategies Stock Performance
NASDAQ PURR traded up $0.45 during trading hours on Tuesday, reaching $7.38. 11,825,610 shares of the stock traded hands, compared to its average volume of 5,039,121. The firm has a market cap of $993.91 million, a P/E ratio of -1.00 and a beta of 1.44. Hyperliquid Strategies has a 1 year low of $3.01 and a 1 year high of $7.80. The firm has a 50 day moving average price of $5.83.
Hyperliquid Strategies Company Profile
Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc, is based in NEW YORK.
See Also
- Five stocks we like better than Hyperliquid Strategies
- AAPL: Forget the iPhone—Services Will Drive the Next Phase of Growth
- Ackman and Berkshire Are Betting Against Each Other on AI
- The $132 Billion Infrastructure Pivot You Might Have Missed
- Nebius Group Pulls Back 9% After a Downgrade Despite Strong Earnings
Receive News & Ratings for Hyperliquid Strategies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hyperliquid Strategies and related companies with MarketBeat.com's FREE daily email newsletter.
